(Alliance News) - Shield Therapeutics PLC shares jumped on Wednesday as its revenue soared in 2024 and it said it expects to be cash flow positive by the end of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback